Announcement
Researchers to share Transpara® breast AI benefits at ECR 2023
Nijmegen, The Netherlands: Date March 1, 2023: Transpara® from ScreenPoint Medical is now being used daily in more than 30
Read more
Nijmegen, The Netherlands: Date March 1, 2023: Transpara® from ScreenPoint Medical is now being used daily in more than 30
Read moreStudies Being Presented at RSNA Shows that the Use of Transpara May Safely Reduce Workload and Maintain Accurate Cancer Detection in
Read moreThe Scandinavian key leaders of AI in breast imaging presented their research at the ScreenPoint symposium at EUSOBI 2022
Read moreScreenPoint Medical, the company that developed the world leading Transpara® AI breast care system, today announced the launch of its
Read moreScandinavia is at the forefront of research and adoption of AI in breast screening. Are you attending EUSOBI 2022 in
Read moreTranspara, the world’s leading artificial intelligence (AI) breast care software, has now reached a major new milestone, helping radiologists read
Read more